Medicenna Therapeutics Corp. (TSX:MDNA)
Canada
· Delayed Price · Currency is CAD 0.850
+0.030 (3.66%)
Mar 9, 2026, 1:03 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 68.40 million as of March 9, 2026. Its market cap has decreased by -28.90% in one year.
Market Cap
68.40M
Enterprise Value
57.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.85
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 65.63M to 68.40M, an increase of 4.23%. That is a compound annual growth rate of 0.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 67.67M |
| ME Therapeutics Holdings | 75.12M |
| NurExone Biologic | 56.27M |
| Sernova Biotherapeutics | 54.63M |
| MedMira | 45.33M |
| Resverlogix | 39.49M |
| BriaCell Therapeutics | 37.49M |
| Defence Therapeutics | 35.57M |